Hjem › Ulcerøs colitis › Virginia
Ulcerøs colitis kliniske forsøg i Virginia
14 studier for Ulcerøs colitis søger deltagere på steder i Virginia.
Byer i Virginia
Officiel studietekst (engelsk)
Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
- University of Virginia Health System ( Site 0291), Charlottesville
RekruttererFase 3
Alle aldre · Alle køn · Opdateret 2. okt. 2026 · NCT06651281Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
- Emeritas Research Group /ID# 284388, Lansdowne Town Center
- GI Alliance - Richmond /ID# 284244, Richmond
RekruttererFase 2
Alder 18 til 75 · Alle køn · Opdateret 2. okt. 2026 · NCT07697456A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
- Gastroenterology Consultants of Southwest Virginia., Roanoke
RekruttererFase 4
Alder 18 til 80 · Alle køn · Opdateret 30. sep. 2026 · NCT06581328Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
- Xencor Investigative Site, Richmond
RekruttererFase 1/2Frivillige med god helbredstilstand velkomne
Alder 18 til 75 · Alle køn · Opdateret 29. sep. 2026 · NCT06619990A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
- Site US-013, Richmond
RekruttererFase 2
Alder 18 til 75 · Alle køn · Opdateret 29. sep. 2026 · NCT07845487A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
- Gastroenterology Associates of Tidewater, Chesapeake
- Blue Ridge Medical Research, Lynchburg
RekruttererFase 3
Alder 12 og opefter · Alle køn · Opdateret 25. sep. 2026 · NCT07196748Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Gastroenterology Consultants of Southwest Virginia, Roanoke
RekruttererFase 3
Alder 18 til 70 · Alle køn · Opdateret 24. sep. 2026 · NCT06937086Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- VCU Massey Comprehensive Cancer Center, Richmond
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 23. sep. 2026 · NCT03816345LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
- Clinical Research Partners, LLC, Richmond
- GI Alliance - Richmond, Richmond
- Carilion Clinic, Roanoke
RekruttererFase 2
Alder 18 til 80 · Alle køn · Opdateret 22. sep. 2026 · NCT07186101A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
- Pediatric Specialists of Virginia, Fairfax
RekruttererFase 3
Alder 2 til 19 · Alle køn · Opdateret 22. sep. 2026 · NCT04844606LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
- Eximia Research-VA, LLC, Norfolk
RekruttererFase 2
Alder 18 til 80 · Alle køn · Opdateret 22. sep. 2026 · NCT07415044An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- Blue Ridge Medical Research - Site Number: 8400020, Lynchburg
- Clinical Research Partners - Site Number: 8400080, Richmond
RekruttererFase 3
Alder 16 til 80 · Alle køn · Opdateret 20. aug. 2026 · NCT07184996A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
- Carilion Children's Tanglewood Center, Roanoke
RekruttererFase 3
Alder 2 og opefter · Alle køn · Opdateret 7. maj 2026 · NCT05442567Ketogenic and Carnivore (Lion) Diets for Inflammatory Bowel Disease and Rheumatoid Arthritis
- Resilient Roots: Functional Medicine, Charlottesville
Rekrutterer
Alder 18 til 64 · Alle køn · Opdateret 16. apr. 2026 · NCT07524244Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.